N/A N=1,267 An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer (VIRGO)
Breast Cancer
Primary: Progression Free Survival — 8.54; 12.88 months
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=13 Valganciclovir Dosing in Pediatric Solid Organ Transplant Recipients
Infection in Solid Organ Transplant Recipients
Primary: Area Under the Curve (AUC) — 21.0 mcg∙h/mL
Phase 1 N=12 Safety Study of TissueGene-C in Degenerative Joint Disease of the Knee
Osteoarthritis, Knee
Primary: Summary of Adverse Events — 2; 2; 3; 2 Adverse events
N/A N=50 Comparison of Coagulation Factors During Laparoscopic Cholecystectomy
Gall Stone Disease · Polyp
Primary: Duration of Operation — 54; 65 minutes
Phase 2 N=159 Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease
Primary: FEV1 AUC 0-12 on Day 7 — 1.452; 1.591; 1.547; 1.539 Liters
Phase 2 N=82 BIIB033 In Acute Optic Neuritis (AON)
Acute Optic Neuritis
Primary: Change in Full-field Visual Evoked Potential (FF-VEP) Latency at Week 24: Intent-to-treat (ITT) Population — 20.83; 17.34 msec — p=0.3337
Phase 1 N=13 A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of PF-04958242 in Healthy Subjects
Healthy
Primary: Area Under the Concentration-Time Profile From Time 0 to Time Tau, the Dosing Interval, Where Tau = 12 Hours (AUCtau) of PF-04958242 — 4242; 4073 picogram*hours per…
N/A N=27 Cortical and Biomechanical Dynamics of Ankle Robotics Training in Stroke
Cerebral Stroke
Primary: Motor Control — 413.22; 523.94 1/s^2
Phase 4 N=40 Fibrinolysis Before Cardiopulmonary Bypass?
Pathologic Fibrinolysis
Primary: Di-Dimer Increase Before Cardiopulmonary Bypass — 317; 266; 317; 291 ng/mL
N/A N=223 Epidemiology and Prevention of Methicillin Resistant Staphylococcus Aureus (MRSA) Transmission in the Community
MRSA - Methicillin Resistant Staphylococcus Aureus Infection
Primary: Recurrent Infection — 1; 3; 1 participants
N/A N=99 Laparoscopic Complete Mesocolic Excision on Colon Cancer
Operation Finding · Complications · Pathology
Primary: Histopathological Outcomes Obtained Through the Surgeries — 20.3; 19.2 nodes
Phase 2 N=1,002 Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)
Dengue Fever
Primary: Geometric Mean Titer (GMT) of Neutralizing Antibodies for Each of the Four Dengue Serotypes Comparing Group D To Groups A and B Combined — 635.04; 181.23; 15104.68…
Phase 4 N=22 Transcranial Direct Current Stimulation, Treatment of Childhood Drug-Resistant Lennox-Gastaut Syndrome, A Pilot Study
Lennox-Gastaut Syndrome
Primary: Number of Seizure After Treatment by tDCS — 80.67; 93.43; 35.53; 93.14 seizures — p=<0.05
Phase 3 N=60 A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
Chronic Hepatitis C Infection · Compensated Cirrhosis
Primary: Percentage of Participants With Sustained Virologic Response 12 Weeks (SVR12) Post-treatment — 100 percentage of participants
Phase 4 N=12 Pharmacokinetic Evaluation of EXPAREL in Adults Undergoing Tonsillectomy
Pain
Primary: Maximum Plasma Concentration (Cmax) — 254 ng/mL